版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
1、Dendritic cells (DCs) have been shown to be able to downregulate immune response, depending on their immature state or tolerogenic/regulatory subsets.The functions of DCs are controlled by a balance of the inhibitory and
2、 activating signals transduced through distinct surface receptors, and preferential expression of inhibitory receptors on DCs can negatively regulateantigen-presentation and cytokine production by DC. Inhibitory receptor
3、-FcyR Ⅱ B play a protective role in the development of autoimmune diseases.Immune complexes (Ics) accumulated in the circulation of lupus not only area major factor in pathological injuries, but also contribute to excess
4、 activationof immune responses to self-antigens by ligation of predominantly expressedactivating FcyRs.Therefore, the primary aim of this study is to investigate whether FcyRⅡ Boverexpressed in immature DC can enhance th
5、e tolerogenecity of immatureDC, especially in the presence of IC, thus leading to the attenuation of the lupus progression by infusion with FcyRⅡ B-overexpressing DC (DC-FcyRⅡB). We found that DC-FcyRⅡB displayed the pro
6、perties of immature DCs,illustrated by expressing moderate levels of costimulatory molecules-CD40,CD80, and CD86, and MHC-Ⅱand by secreting Iow levels of proinflammatory cytokines-TNF-α and IL-1β and large amounts of inh
7、ibitoryfactor-PGE2 upon exposure to IC. These IC-treated DC-FcyR!!B induced hyporesponses of T cells and mediated inhibitory effects on the OVA-specificT cells responses to mature and activated DCs partially dependent on
8、 PGE2production. Moreover, we found that DC-FcyRⅡB obviously prolonged the survival of MRL/Ipr, reduced the generation of serum autoantibodies specificfor DNA or chromatin and the Ics deposition in kidney, and ameliorate
9、d ofkidney pathological injury. Our results demonstrated that inhibitory FcyRⅡB-modified overexpressing DCs can downregulate immune response and infusion with FcyR Ⅱ B-overexpressing DCs may be used as a noveltherapeutic
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- HCV C-Fc融合基因疫苗修飾的樹突狀細(xì)胞功能研究.pdf
- 含小鼠FcγRⅡb基因慢病毒載體對MRL-lpr SLE小鼠的作用研究.pdf
- RNA干擾樹突狀細(xì)胞對狼瘡腎炎小鼠的治療研究.pdf
- 腫瘤抗原修飾的樹突狀細(xì)胞活性研究.pdf
- 小鼠骨髓來源調(diào)節(jié)性樹突狀細(xì)胞的體外培養(yǎng)和鑒定.pdf
- 修飾樹突狀細(xì)胞抗胃癌免疫功能調(diào)節(jié)的研究.pdf
- LPS刺激的小鼠骨髓來源樹突狀細(xì)胞生長和細(xì)胞周期分析.pdf
- 小鼠腸癌RNA轉(zhuǎn)染mIL-12修飾樹突狀細(xì)胞激發(fā)抗腫瘤活性研究.pdf
- 樹突狀細(xì)胞和白細(xì)胞介素-2聯(lián)合對小鼠大腸癌治療的實(shí)驗(yàn)研究.pdf
- 靶向基因修飾樹突狀細(xì)胞瘤苗治療移植性肝癌的實(shí)驗(yàn)研究.pdf
- 小鼠子宮蛻膜基質(zhì)細(xì)胞促進(jìn)樹突狀細(xì)胞的增殖.pdf
- IL-2基因修飾的樹突狀細(xì)胞免疫治療肝癌的實(shí)驗(yàn)研究.pdf
- 調(diào)節(jié)性樹突狀細(xì)胞對克羅恩病小鼠模型的治療作用.pdf
- HBcAg和HBeAg對小鼠骨髓源性樹突狀細(xì)胞功能的影響.pdf
- 植物活性多糖對小鼠樹突狀細(xì)胞和巨噬細(xì)胞功能的調(diào)節(jié)作用.pdf
- DON對小鼠骨髓源性樹突狀細(xì)胞的細(xì)胞表型和免疫功能的影響.pdf
- 創(chuàng)傷膿毒癥小鼠腸道和外周血樹突狀細(xì)胞變化的實(shí)驗(yàn)研究.pdf
- HBeAg對小鼠骨髓源性樹突狀細(xì)胞成熟和功能的影響.pdf
- 耐受性樹突狀細(xì)胞治療小鼠炎癥性腸病的療效研究.pdf
- 白細(xì)胞介素18基因修飾的成熟樹突狀細(xì)胞疫苗對哮喘小鼠的治療作用及其相關(guān)機(jī)制的研究.pdf
評論
0/150
提交評論